Federal Agencies Advance Psychedelic Therapy Following Trump’s Executive Order

How will FDA regulate psychedelics?

FDA has been taking a look at psychedelics as a potential treatment for psychiatric and substance abuse disorders, recently publishing a final guidance for drug sponsors conducting clinical trials of psychedelics, including psilocybin, LSD, and MDMA.  This episode is available on Spotify, Apple Podcasts, and Youtube. “This is of interest to psycho-oncologists that have been looking into this question for at least two decades around cancer-relat…

Federal Agencies Advance Psychedelic Therapy Following Trump's Executive Order

Federal agencies are advancing legal psychedelic therapy after President Donald Trump signed an Executive Order to accelerate the process. As of now, most psychedelics, including psilocybin, LSD, DMT, and ibogaine, remain federally illegal as Schedule I substances. Trump Accelerating Psychedelic Therapy for Mental Illness  Trump’s Executive Order, signed earlier in spring 2026, established the need […] Source: Federal Agencies Advance Psychedeli…

Federal Agencies Advance Psychedelic Therapy Following Trump’s Executive Order

Federal agencies are advancing legal psychedelic therapy after President Donald Trump signed an Executive Order to accelerate the process. As of now, most psychedelics, including psilocybin, LSD, DMT, and ibogaine, remain federally illegal as Schedule I substances. Trump Accelerating Psychedelic Therapy for Mental Illness Trump's Executive Order, signed earlier in spring 2026, established the need [ . . . ] Source: Federal Agencies Advance Psych…